Copegus [clinicaltrials_resource:901cb3af837b4560efe5c91eef5755c1]
intervention [clinicaltrials_vocabulary:intervention]
Copegus [clinicaltrials_resource:901cb3af837b4560efe5c91eef5755c1]
Bio2RDF identifier
901cb3af837b4560efe5c91eef5755c1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:901cb3af837b4560efe5c91eef5755c1
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
400-1200 mg/day for 48 weeks
intervention name [clinicaltrials_vocabulary:intervention-name]
other name [clinicaltrials_vocabulary:other-name]
(ribavirin, Ro20-9963)
identifier
clinicaltrials_resource:901cb3af837b4560efe5c91eef5755c1
title
Copegus
@en
type
label
Copegus [clinicaltrials_resource:901cb3af837b4560efe5c91eef5755c1]
@en